Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients

Shinpei Tsuchida (Miyazaki-shi, Japan), Shinpei Tsuchida, Hironobu Tsubouchi, Akiko Kitamura, Nobuhiro Matsumoto, Masamitsu Nakazato

Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Session: Lung cancer: therapeutic modalities, re-staging, and follow-up
Session type: Poster Discussion
Number: 4842

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Shinpei Tsuchida (Miyazaki-shi, Japan), Shinpei Tsuchida, Hironobu Tsubouchi, Akiko Kitamura, Nobuhiro Matsumoto, Masamitsu Nakazato. Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients. Eur Respir J 2016; 48: Suppl. 60, 4842

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic factors for stage IV lung adenocarcinoma patients receiving retreatment with EGFR-TKI
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015


Chemotherapy in elderly patients with non-small-cell lung cancer in Tunisian respiratory department
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013


Survival in lung cancer: Associated factors in Tunisian patients
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015


Age related influence of COPD on postoperative pulmonary morbidity in lung cancer patients
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013

Efficiency of erythropoiesis-stimulating agents (ESA) in the treatment of chemotherapy-induced anemia in patients with lung cancer (LC)
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015

Is the lung cancer in elderly similar to lung cancer in younger patients?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


Comorbitities, responses and survival in pts with NSCLC
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Mortality in asymptomatic vs. symptomatic patients surgically treated for non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013


Survival in patients with lung cancer, with and without self reported cardiovascular disease the HUNT study
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014


Influence of anxiety and depression on one-year survival in lung cancer patients
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016

Risk factors for prolonged postoperative air leak-a retrospective analysis of 853 partial lung resections for non-small cell lung cancer
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013


Delay in diagnosis and management of lung cancer in developing countries
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016


The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016

Evaluation of incidental lung cancer in hospitalized patients with non-respiratory disease
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016


Impact of acute admissions and readmissions in patients with lung cancer for patients and the hospital
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014


Prognostic factors for survival in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Approach to hypersensitivity reactions to chemotherapeutics in patients with lung cancer
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013

Prevalence and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early stage of COPD
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

Weight loss cutoff level as a key variable related to death risk among advanced lung cancer patients
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Physiological predictors of mortality in high-risk patients undergoing surgery for lung cancer
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016